http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-1779381-C

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_436bf8b26cec1afd297564c261a8a78e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3fc0c0c9cfd0c12387f5af09a36a5348
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e1b250b0ddd979f0056bfb47f4bd8217
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_08b36def6d0fd303e6e9f2f0c66c34e5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e6d309871f39fd7981e021fd9c8f7f6f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3db1550bf3d467b3f2fd69e4634e6e73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c999ea759d9a5d7f3df575afcae2f1e1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e1642d068126fec186e51e3223ef0883
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-44
filingDate 1991-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1992-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b44f79272cc2073daecac3281149bf20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23f08513e55e65c3b4a4b4c4f1cef414
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0fe7f148744b317894da00bffac355d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96d977ad03c43d81df7958f3c27467bc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9beb6e91bfd30a87b79891da9bfa455
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9738d734f2a36b1f3ac2d5a4de0c0fc0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73c8067b9f8775d43812fd0d921d9805
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0905792f1029bca0c071736dee99e862
publicationDate 1992-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-1779381-C
titleOfInvention An antiherpetic agent
abstract The invention relates to medicine and can be used as a medicine for the treatment of lesions caused by herpes simplex virus. In order to increase the activity of the agent, the latter contains α-lysine-α-oxidase and an excipient in the following ratio of components, wt.%. a-lysine-a oxidase 0.001-0.1; filler rest.
priorityDate 1991-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416175691
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID162683
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID162683
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10298
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID60711
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID60711
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2761529
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID515951
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10298

Total number of triples: 34.